The estimated Net Worth of Timothy J Scannell is at least $21 Million dollars as of 10 September 2024. Mr. Scannell owns over 5,000 units of Stryker stock worth over $11,205,181 and over the last 16 years he sold SYK stock worth over $2,689,294. In addition, he makes $7,113,230 as President and Chief Operating Officer at Stryker.
Sign up
Mr. Scannell SYK stock SEC Form 4 insiders trading
timothy has made over 36 trades of the Stryker stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of SYK stock worth $1,129,200 on 10 September 2024.
The largest trade he's ever made was exercising 98,590 units of Stryker stock on 23 November 2020 worth over $5,935,118. On average, timothy trades about 8,691 units every 69 days since 2009. As of 10 September 2024 he still owns at least 30,586 units of Stryker stock.
You can see the complete history of Mr. Scannell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
timothy Scannell biography
Timothy J. Scannell serves as President, Chief Operating Officer of the Company. He began his career with Stryker in 1990 with our Endoscopy division, where he served in various sales and marketing leadership roles. Mr. Scannell progressed to the position of Executive Vice President, overseeing sales, marketing and operations. In 2001, he was appointed Vice President and General Manager of our Biotech division. In 2003, he was named Vice President and General Manager of our Spine division and was later promoted to President of Spine. In 2009, he was appointed to the position of Group President and initially was responsible for the Spine and Endoscopy divisions. Over time, the role expanded to include MedSurg and Neurotechnology, with each of the group’s divisional leaders reporting to him. He serves on the Board of Directors for Insulet Corporation, whose OmniPod®Insulin Management System helps to improve the lives of people with diabetes.
What is the salary of timothy Scannell?
As the President and Chief Operating Officer of Stryker, the total compensation of timothy Scannell at Stryker is $7,113,230. There are 1 executives at Stryker getting paid more, with Kevin Lobo having the highest compensation of $14,974,800.
How old is timothy Scannell?
timothy Scannell is 55, he's been the President and Chief Operating Officer of Stryker since 2018. There are 9 older and 10 younger executives at Stryker. The oldest executive at Stryker Corp. is Srikant Datar, 67, who is the Independent Director.
What's timothy Scannell's mailing address?
Timothy's mailing address filed with the SEC is 2825, Airview Boulevard, Kalamazoo, Kalamazoo County, Michigan, 49002, United States.
Insiders trading at Stryker
Over the last 21 years, insiders at Stryker have traded over $2,226,515,535 worth of Stryker stock and bought 219,711 units worth $9,400,673 . The most active insiders traders include Ronda E Stryker, Pat Stryker, and Jon L Stryker. On average, Stryker executives and independent directors trade stock every 6 days with the average trade being worth of $10,449,767. The most recent stock trade was executed by Viju Menon on 27 August 2024, trading 600 units of SYK stock currently worth $213,000.
What does Stryker do?
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
What does Stryker's logo look like?
Complete history of Mr. Scannell stock trades at Exact Sciences, Insulet, NovoCure Ltd, and Stryker
Stryker executives and stock owners
Stryker executives and other stock owners filed with the SEC include:
-
Kevin Lobo,
Chairman of the Board, Chief Executive Officer -
timothy Scannell,
President, Chief Operating Officer -
Glenn Boehnlein,
Chief Financial Officer, Vice President -
Robert Fletcher,
Vice President, Chief Legal Officer -
Viju Menon,
Group President - Global Quality and Operations -
Kevin A. Lobo,
Chairman, CEO & Pres -
Timothy J. Scannell,
Pres & COO -
Glenn S. Boehnlein,
VP & CFO -
Viju S. Menon,
Group Pres of Global Quality & Operations -
Robert S. Fletcher,
VP & Chief Legal Officer -
Allan Golston,
Lead Independent Director -
Andrew Silvernail,
Independent Director -
Roch Doliveux,
Independent Director -
Sherilyn McCoy,
Independent Director -
Rajeev Suri,
Independent Director -
Ronda Stryker,
Independent Director -
Srikant Datar,
Independent Director -
Mary Brainerd,
Independent Director -
Preston Wells,
Vice President - Investor Relations -
Yin Becker,
Vice President - Communications, Public Affairs and Corporate Marketing -
William Berry,
Principal Accounting Officer, Vice President, Corporate Controller -
M. Kathryn Fink,
Chief Human Resource Officer, Vice President -
M. Kathryn Fink,
VP & Chief HR Officer -
William E. Berry Jr.,
VP & Chief Accounting Officer -
Dana S. McMahon,
VP & Chief Compliance Officer -
Alan Douville,
VP, Chief Information Officer & Chief Information Security Officer -
Robert C. Cohen,
CTO and VP of Global R&D - Joint Replacement -
Louise Francesconi,
Director -
David Floyd,
Group President, Orthopaedics -
Bijoy Sagar,
VP, Chief Information Officer -
Howard E Jr Cox,
Director -
Graham A Mc Lean,
President, Asia-Pacific -
Lonny J Carpenter,
Group President -
Michael Damon Hutchinson,
General Counsel -
Katherine Ann Owen,
VP, Strategy and IR -
William R Jellison,
VP and CFO -
Curtis E Hall,
VP, General Counsel -
Steven P Benscoter,
VP, Human Resources -
Howard L Lance,
Director -
Donald M Engelman,
Director -
Andrew Grant Fox Smith,
President -
Michael P Mogul,
Group President -
Tony M Mc Kinney,
V.P., CAO -
Stephen P Macmillan,
President and COO -
Marcia S Kaminsky,
V.P., Comms. & Public Affairs -
Michael W Rude,
VP of Human Resources -
Curt R Hartman,
V.P., Finance -
Ramesh Subrahmanian,
Group President, International -
Scott P Bruder,
VP, Chief Med&Scientific Off. -
Luciano Cattani,
V.P. -
James E Kemler,
Vice President -
Thomas R Winkel,
Vice Pesident -
John W Brown,
Chairman and CEO -
Jon L Stryker,
10% owner -
Pat Stryker,
10% owner -
Jerome H Grossman,
Director -
John S Lillard,
Director -
Dean H Bergy,
Vice President, CFO & Secretar -
James R Lawson,
Vice President -
Gerard Thomas,
10% owner -
Stephen Si Johnson,
Vice President -
Mason Elizebeth S Upjohn,
10% owner -
Edward B Lipes,
Vice President -
William U Parfet,
Director -
Tatum Lisa M Skeete,
Director -
Rachel Ruggeri,
Director -
Giovanni Caforio,
Director -
James Andrew Pierce,
Group President -
Spencer S Stiles,
Group President